Lilly Teams Up With Synthes To Develop and Commercialize Bone Healing Therapies
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug-device company development collaborations are common, but the range, commercial nature and expected duration of the Synthes/Lilly deal is unusual.